Cargando…

Butyric acid in irritable bowel syndrome

Butyric acid (butanoic acid) belongs to a group of short-chain fatty acids and is thought to play several beneficial roles in the gastrointestinal tract. Butyric anion is easily absorbed by enteric cells and used as a main source of energy. Moreover, butyric acid is an important regulator of colonoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Załęski, Andrzej, Banaszkiewicz, Aleksandra, Walkowiak, Jarosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027835/
https://www.ncbi.nlm.nih.gov/pubmed/24868283
http://dx.doi.org/10.5114/pg.2013.39917
_version_ 1782317000734801920
author Załęski, Andrzej
Banaszkiewicz, Aleksandra
Walkowiak, Jarosław
author_facet Załęski, Andrzej
Banaszkiewicz, Aleksandra
Walkowiak, Jarosław
author_sort Załęski, Andrzej
collection PubMed
description Butyric acid (butanoic acid) belongs to a group of short-chain fatty acids and is thought to play several beneficial roles in the gastrointestinal tract. Butyric anion is easily absorbed by enteric cells and used as a main source of energy. Moreover, butyric acid is an important regulator of colonocyte proliferation and apoptosis, gastrointestinal tract motility and bacterial microflora composition in addition to its involvement in many other processes including immunoregulation and anti-inflammatory activity. The pathogenesis of irritable bowel syndrome (IBS), the most commonly diagnosed functional gastrointestinal condition, is complex, and its precise mechanisms are still unclear. This article describes the potential benefits of butyric acid in IBS.
format Online
Article
Text
id pubmed-4027835
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-40278352014-05-27 Butyric acid in irritable bowel syndrome Załęski, Andrzej Banaszkiewicz, Aleksandra Walkowiak, Jarosław Prz Gastroenterol Review Papers Butyric acid (butanoic acid) belongs to a group of short-chain fatty acids and is thought to play several beneficial roles in the gastrointestinal tract. Butyric anion is easily absorbed by enteric cells and used as a main source of energy. Moreover, butyric acid is an important regulator of colonocyte proliferation and apoptosis, gastrointestinal tract motility and bacterial microflora composition in addition to its involvement in many other processes including immunoregulation and anti-inflammatory activity. The pathogenesis of irritable bowel syndrome (IBS), the most commonly diagnosed functional gastrointestinal condition, is complex, and its precise mechanisms are still unclear. This article describes the potential benefits of butyric acid in IBS. Termedia Publishing House 2013-12-30 2013 /pmc/articles/PMC4027835/ /pubmed/24868283 http://dx.doi.org/10.5114/pg.2013.39917 Text en Copyright © 2013 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Papers
Załęski, Andrzej
Banaszkiewicz, Aleksandra
Walkowiak, Jarosław
Butyric acid in irritable bowel syndrome
title Butyric acid in irritable bowel syndrome
title_full Butyric acid in irritable bowel syndrome
title_fullStr Butyric acid in irritable bowel syndrome
title_full_unstemmed Butyric acid in irritable bowel syndrome
title_short Butyric acid in irritable bowel syndrome
title_sort butyric acid in irritable bowel syndrome
topic Review Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027835/
https://www.ncbi.nlm.nih.gov/pubmed/24868283
http://dx.doi.org/10.5114/pg.2013.39917
work_keys_str_mv AT załeskiandrzej butyricacidinirritablebowelsyndrome
AT banaszkiewiczaleksandra butyricacidinirritablebowelsyndrome
AT walkowiakjarosław butyricacidinirritablebowelsyndrome